BioSpace News Archive

There has been augmented focus on personalized medicines and drug discovery utilizing in vitro methods. In addition, the demand for humanized animal models is also witnessing a rise, which is likely to open plethora of opportunities for the players in the global genetic toxicology testing market in the near future

InnerScope Hearing Technologies Inc. is pleased to announce that the FDA has released the “Final Rule” for creating a new category of Over-the-Counter hearing aids for perceived mild to moderate hearing losses to be sold directly to consumers in retail stores, pharmacies and online without a medical exam or being fitted by a hearing healthcare professional.

SHINE Technologies, LLC, a next-generation fusion technology company, announced Tom D’Orazio has joined as the CEO of Phoenix LLC.

Vuzix® Corporation announced that its M400 smart glasses are currently being trialed in Japan for an emergency medical care plan with the objective of providing early treatment in an effort to improve patient outcomes and lifesaving rates for critically ill patients undergoing transport to the hospital.

Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery announced the successful first surgeries of the Spartan™ Stem and Logical™ Cup System for total hip arthroplasty.

EvoNexus, California’s leading non-profit tech incubator, selected CRISPR QC to become a portfolio company.

VySpine, a spine innovation leader using differentiated materials and designs, announced today that it has received 510(k) clearance from the FDA for its VyPlate Anterior Cervical Plate System.

LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, has launched the Small Cell Lung Cancer Patient Gateway.

Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor events.

Chicago Pacific Founders is pleased to announce that it, along with Magruder Eye Institute and Robson Eye Institute, has formed Ascend Vision Partners.